RMB advised Mediclinic on its R8.4-bn acquisition of a 29.9% stake in LSE listed Spire Healthcare Group plc and R10-bn rights issue.
Rand Merchant Bank is proud to have advised Mediclinic on the acquisition of a 29.9% stake in Spire Healthcare Group– a leading private healthcare group in the United Kingdom, funded by way of a ZAR10-billion rights issue. RMB also provided bridging finance to facilitate the conclusion of the acquisition. The deal further diversifies Mediclinic’s business into an attractive offshore geography. The successful conclusion of the acquisition and rights issue highlights RMB’s ability to conclude large multi-disciplinary, cross border transactions.